17. December 2024 | Corporate News

Marinomed Biotech AG: Requirements for successful completion of the restructuring proceedings achieved

  • Funds deposited for cash quota and to cover legal costs
  • European Investment Bank (EIB) agrees to standstill declaration
  • Implementation of the restructuring plan and the Company's sustainable continued existence are to be secured by the sale of the Carragelose business

 

The full press release is available as download here:

Marinomed Biotech AG: Requirements for successful completion of the restructuring proceedings achieved
(54 KB)